Consultation

ICIS is implementing a process of rolling consultation on all of its methodologies. This consultation paper is part of this formal process and covers all of the ICIS primary price points included in the caprolactam weekly publications.

The consultation asked both general questions about the suitability of the ICIS methodology and questions addressing specific caprolactam market issues.

Click here to download the Caprolactam Consultation

There were no formal responses to consultation GMC 25/14. ICIS will not be proposing any immediate changes to the methodology of the Caprolactam Report. Any decision to change this methodology will be communicated to subscribers using the usual channels and with the usual notice period.

ICIS continues to welcome any feedback on its Caprolactam methodology outside of the formal consultation process.

To provide further comments or feedback please contact Barbara Ortner, Head of Market Reporting: Barbara.Ortner@icis.com

Consultation on this document closed on 19 September 2014